The clinical trial ecosystem is a complex web of investigator sites, laboratories, couriers, patient samples and more. The ability to track those samples though this ecosystem with full visibility for the sponsor is essential for a successful trial. In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, describes that ecosystem and the lifecycle of patient samples. She describes: The varying approaches of small vs. large laboratories Risks of insufficient tracking Tracking consent for future use Current practice and opportunities for improved tracking Learn more at https://www.q2labsolutions.com/labmatrix